United States · FDA National Drug Code directory
Zenpep
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73562-116_6b24ef38-2c65-4b1d-804a-a8301db084e6
- Product NDC
- 73562-116
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- pancrelipase lipase, pancrelipase protease, pancrelipase amylase
- Labeler
- Aimmune Therapeutics, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20201101
- Source listing expiry
- 20261231
Source-listed ingredients
- PANCRELIPASE LIPASE — 25000 [USP'U]/1
- PANCRELIPASE PROTEASE — 79000 [USP'U]/1
- PANCRELIPASE AMYLASE — 105000 [USP'U]/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (73562-116-01) · 73562-116-01
- 12 CAPSULE, DELAYED RELEASE in 1 BOTTLE (73562-116-12) · 73562-116-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →